ETON PHARMACEUTICALS, INC.

Analyst Reco. Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
3.12 ^USD	-2.80%		+1.96%	-28.77%

Apr. 17	Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024	CI
Apr. 15	Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating	23-08-11	MT
HC Wainwright Trims Price Target on Eton Pharmaceuticals to $9 From $10, Maintains Buy Rating	23-07-03	MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $10 From $9, Keeps Buy Rating	22-09-26	MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $9 from $11, Keeps Buy Rating	22-07-25	MT
B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating	22-06-01	MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $11 From $14, Keeps Buy Rating	22-03-22	MT
ETON PHARMACEUTICALS : B. Riley Resumes Eton Pharmaceuticals at Buy with $10 PT, Sees Potential in 'Robust' Pipeline Despite Regulatory Challenges, Related Delays	21-10-14	MT
ETON PHARMACEUTICALS : B. Riley Lowers Eton Pharmaceuticals' PT to $11 from $13 on Lowered Probability of Success for DS100, Keeps Buy Rating	21-06-01	MT
ETON PHARMACEUTICALS : HC Wainwright Adjusts Eton Pharmaceuticals's Price Target to $15 From $20, Keeps at Buy	21-01-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer